In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Exiqon and Link Technologies sign supply agreement
Exiqon and IBA Gmbh announce license agreement on SALE of Locked Nucleic Acid (LNA™)
EXIQON LICENSES MICRORNA PCR TECHNOLOGY FROM ROSETTA INPHARMATICS
EXIQON LICENSES LOCKED NUCLEIC ACIDS FOR SIRNA TO APPLIED BIOSYSTEMS
EXIQON LICENSES LOCKED NUCLEIC ACIDTM TECHNOLOGY TO INVITROGEN FOR SAMPLE PREPARATION PRODUCTS
Exiqon and Proligo to build global LNA business
EXIQON TO ACQUIRE ONCOTECH INC AND ENTER THE MARKET FOR CANCER MOLECULAR DIAGNOSTICS IN 2008
EXIQON FORMS RESEARCH COLLABORATION WITH M. D. ANDERSON CANCER CENTER